For more than 20 years, Celiac Disease Foundation has been the trusted source for the dissemination of evidence-based research regarding celiac disease. CEO Marilyn G. Geller challenges the science behind a controversial new report alleging that genetically engineered foods could be an environmental trigger for celiac disease and gluten sensitivity.
Celiac Disease Foundation drives diagnosis and treatment of celiac disease through advocacy, education and advancing research to improve the quality of life for all people affected by gluten-related disorders
FDA clarifies what the Gluten-Free Labeling Rule means for restaurants – considers enforcement action to protect consumers
Alvine Pharmaceuticals, Inc., a biopharmaceutical company focused on the treatment of autoimmune and gastrointestinal diseases, today announced that the first randomized study patient was dosed in the CeliAction Study™
Kathy Giusti, CEO of the Multiple Myeloma Research Foundation (MMRF). Marilyn Geller, CEO of the Celiac Disease Foundation (CDF). What do these women have in common? They are leading dynamic, nonprofit organizations that are driving innovation, awareness and research in diseases once relatively unknown or incurable-and they’re all coming at it from a personal connection. […]